메뉴 건너뛰기
Neurology
Volumn 85, Issue 4, 2015, Pages 381-383
Neuromyelitis optica in a child with Aicardi-Goutières syndrome
Author keywords

[No Author keywords available]
Indexed keywords

AQUAPORIN 4 ANTIBODY; MYCOPHENOLATE MOFETIL; RITUXIMAB; STEROID; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN;
EID: 84946894084     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001792     Document Type: Article
Times cited : (19)
References (7)
  • 1
    • 84887607415 scopus 로고    scopus 로고
    • Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study
    • Rice GI, Forte GM, Szynkiewicz M, et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013;12:1159-1169.
    • (2013) Lancet Neurol , vol.12 , pp. 1159-1169
    • Rice, G.I.1    Forte, G.M.2    Szynkiewicz, M.3
  • 2
    • 85027910962 scopus 로고    scopus 로고
    • Aicardi-Goutieres syndrome harbours abundant systemic and brain-reactive autoantibodies
    • Cuadrado E, Vanderver A, Brown KJ, et al. Aicardi-Goutieres syndrome harbours abundant systemic and brain-reactive autoantibodies. Ann Rheum Dis 2014.
    • (2014) Ann Rheum Dis
    • Cuadrado, E.1    Vanderver, A.2    Brown, K.J.3
  • 3
    • 84908699156 scopus 로고    scopus 로고
    • Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia
    • Crow YJ, Zaki MS, Abdel-Hamid MS, et al. Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. Neuropediatrics 2014;45:386-393.
    • (2014) Neuropediatrics , vol.45 , pp. 386-393
    • Crow, Y.J.1    Zaki, M.S.2    Abdel-Hamid, M.S.3
  • 4
    • 10344250945 scopus 로고    scopus 로고
    • A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
    • Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
    • (2004) Lancet , vol.364 , pp. 2106-2112
    • Lennon, V.A.1    Wingerchuk, D.M.2    Kryzer, T.J.3
  • 5
    • 84896801184 scopus 로고    scopus 로고
    • Comparison of relapse and treatment failure rates among patients with neuromyelitis optica multicenter study of treatment efficacy
    • Mealy MA, Wingerchuk DM, Palace J, Greenberg BM, Levy M. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica multicenter study of treatment efficacy. JAMA Neurol 2014;71:324-330.
    • (2014) JAMA Neurol , vol.71 , pp. 324-330
    • Mealy, M.A.1    Wingerchuk, D.M.2    Palace, J.3    Greenberg, B.M.4    Levy, M.5
  • 6
    • 38349056680 scopus 로고    scopus 로고
    • Neuromyelitis optica and non organ-specific autoimmunity
    • Pittock SJ, Lennon VA, de Seze J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008;65:78-83.
    • (2008) Arch Neurol , vol.65 , pp. 78-83
    • Pittock, S.J.1    Lennon, V.A.2    De Seze, J.3
  • 7
    • 84858167672 scopus 로고    scopus 로고
    • Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays
    • Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays. Neurology 2012;78:665-671.
    • (2012) Neurology , vol.78 , pp. 665-671
    • Waters, P.J.1    McKeon, A.2    Leite, M.I.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.